...also in Adam Feuerstein's article it says "The scientific community and most of Wall Street know this and have moved on from dendritic cancer vaccines. Today's buzz is antibody-based cancer immunotherapy"... and this is exactly what ENTB is working on! ...I guess that BMSN is covering both angles through both Regen and Entest!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.